News & Events


May 09, 2022

CRYOcheck™ Chromogenic Factor IX Assay Authorized for Sale in Canada, EU, UK, and Australasia

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the launch of its new CRYOcheck Chromogenic Factor IX assay in Canada, the European Union, United Kingdom, Australia, and New Zealand following market authorization by Health Canada and respective in-country regulatory authorities. The announcement was made at the World Federation of Hemophilia Congress taking place in Montreal, May 8–11, 2022.

April 28, 2022

The teams from Precision BioLogic and Affinity Biologicals will be at the WFH 2022 World Congress in Montreal, May 8 to 11. Be sure to visit us at Booth 1708 to find out what we've been up to!


Here’s a list of conferences we’ll be attending this year. If you’re planning on attending any of the same shows, be sure to swing by our booth for a chat because, after all, it’s you we want to see.

May 08 to 11
Montreal, Quebec - Visit us at booth 1708
Jul 09 to 13
London, England - Visit us at Booth 1210
Aug 16 to 18
Chicago, IL - Visit us at Booth 401
Sep 15 to 16
Leiden, The Netherlands